ChinaBio Today -- Lijun International Pharmaceutical (Holding) Co. and its subsidiaries expect their six months’ profit for 2009 to be roughly equal to the net income for the entire year 2008. Lijun earned HK$102,106,000 ($13.2 million) last year. Mr. Wu Qin, Chairman of Lijun International, said stable prices combined with growth in the domestic pharmaceutical market translated to an increase in gross profit margins.
